Icu Medical ICUI Income Statement (2009-2026)

NASDAQ ICUI
$152.65 -0.26 (-0.17%)
At close: Sep 18, 2026 · 4:00 PM EDT
Reported Financials

Icu Medical Quarterly Income Statement

Periods 70 quarters
Latest Jun 2026

Icu Medical reported revenue of $551.68M and net income of $19.09M for the quarter ended Jun 2026, up 0.5% year over year. This income statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
336.06M340.52M543.12M561.00M597.86M578.01M568.65M549.31M553.31M587.86M566.65M596.46M589.13M629.80M604.70M548.87M536.99M540.70M530.23M551.68M
Cost of RevenueCost of Rev
208.27M213.03M374.30M393.41M411.46M403.07M376.61M356.98M369.39M416.27M381.41M389.03M384.28M402.55M394.59M340.80M336.11M337.72M324.00M316.63M
Gross Profit
127.79M127.49M168.83M167.59M186.40M174.94M192.04M192.33M183.92M171.59M185.24M207.43M204.85M227.26M210.11M208.06M200.88M202.99M206.23M235.05M
Operating items
Research & DevelopmentR&D
12.24M13.17M23.87M22.56M23.11M23.45M19.76M22.30M20.87M22.41M21.84M23.39M21.03M22.36M23.29M21.87M21.25M21.09M21.28M22.70M
Selling, General & AdministrativeSG&A
74.81M81.46M153.21M158.75M153.45M142.93M152.57M150.90M148.61M154.62M157.66M159.55M162.71M158.85M157.23M159.39M152.77M155.81M154.57M151.92M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
2.36M9.04M33.91M-13.67M10.31M8.79M10.31M16.37M-8.41M6.74M16.40M16.70M41.82M2.97M16.80M
Operating ExpensesOpex
89.41M103.67M210.99M167.64M186.86M175.17M182.65M189.57M161.07M183.77M195.90M199.74M196.62M189.57M197.22M197.48M187.16M197.35M192.65M195.93M
Operating IncomeOp. Inc
38.38M23.82M-42.16M-0.05M-0.47M-0.22M9.39M2.76M22.85M-12.18M-10.65M7.69M8.24M37.69M12.89M10.59M13.72M5.63M13.58M39.13M
EBIT
38.38M23.82M-42.16M-0.05M-0.47M-0.22M9.39M2.76M22.85M-12.18M-10.65M7.69M8.24M37.69M12.89M10.59M13.72M5.63M13.58M39.13M
Non-operating items
Non Operating Interest Expenses
0.17M0.37M13.05M15.44M17.81M22.52M24.12M24.18M23.77M23.84M24.68M22.03M20.55M19.81M16.49M15.75M
Interest & Investment IncomeInt & Inv Inc
1.22M1.82M1.82M1.82M1.82M1.82M1.82M1.88M1.92M
Other Non Operating IncomeOther Non Op Inc.
20.85M20.85M-89.55M-122.97M24.84M20.71M-76.78M-99.60M-115.47M-146.94M-107.05M75.05M-27.02M-47.27M
Non Operating IncomeNon Op. Inc.
-0.29M-2.96M0.41M-1.37M-3.03M-1.15M-0.27M-1.50M-4.04M-0.09M-2.34M-3.38M-1.48M-6.02M-1.76M1.82M0.61M-0.89M-1.06M-0.24M
Net income details
EBT
37.92M23.34M-54.80M-16.85M-21.31M-21.45M-13.39M-22.86M-5.37M-36.68M-36.77M-19.53M-17.93M8.22M-10.91M33.68M-2.51M-15.90M-3.98M23.14M
Tax ProvisionsTaxes
6.84M3.41M-16.73M-9.38M-8.10M-5.91M-3.58M-12.93M-12.60M-19.53M2.70M1.87M15.05M32.05M4.57M1.18M-0.66M-2.65M-34.71M7.07M
Profit After TaxPAT
31.08M19.93M-38.07M-7.47M-13.21M-15.54M-9.81M-9.93M7.24M-17.15M-39.47M-21.41M-32.98M-23.83M-15.48M35.34M-3.40M-14.54M30.13M19.09M
Equity Income
2.84M-1.54M-2.48M-0.61M3.01M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
31.08M19.93M-38.07M-7.47M-13.21M-15.54M-9.81M-9.93M7.24M-17.15M-39.47M-21.41M-32.98M-23.83M-15.48M32.50M-1.85M-13.25M30.74M16.07M
Consolidated Net IncomeConsol Net Inc.
31.08M19.93M-38.07M-7.47M-13.21M-15.54M-9.81M-9.93M7.24M-17.15M-39.47M-21.41M-32.98M-23.83M-15.48M32.50M-1.85M-13.25M30.74M16.07M
Income towards Parent CompanyParent Net Inc
31.08M19.93M-38.07M-7.47M-13.21M-15.54M-9.81M-9.93M7.24M-17.15M-39.47M-21.41M-32.98M-23.83M-15.48M32.50M-1.85M-13.25M30.74M16.07M
Preferred Dividend PaymentsPref Dividends
-7.55M-6.82M-2.62M-2.29M-1.66M
Net Income towards Common StockholdersNet Income
31.08M19.93M-38.07M-7.47M-13.21M-15.54M-9.81M-9.93M7.24M-17.15M-31.92M-14.59M-32.98M-23.83M-12.85M34.79M-1.85M-13.25M32.40M16.07M
Additional items
EPS (Basic)
1.470.94-1.61-0.31-0.55-0.65-0.41-0.410.30-0.71-1.32-0.60-1.35-0.98-0.521.41-0.08-0.541.310.64
EPS (Diluted)
1.430.91-1.61-0.31-0.55-0.65-0.41-0.410.30-0.71-1.32-0.60-1.35-0.98-0.521.41-0.08-0.531.290.64
Shares Outstanding
21.21M21.21M23.65M23.90M23.91M23.87M24.01M24.07M24.13M24.09M24.22M24.39M24.44M24.39M24.54M24.64M24.69M24.64M24.76M25.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
21.73M21.78M23.65M23.90M23.91M23.87M24.01M24.07M24.37M24.09M24.22M24.39M24.44M24.39M24.54M24.71M24.69M24.90M25.18M25.04M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
21.24M21.28M23.88M23.90M23.98M23.99M24.06M24.10M24.14M24.14M24.36M24.43M24.46M24.52M24.61M24.68M24.69M24.69M24.99M25.01M
EBITDA
38.38M23.82M-42.16M-0.05M-0.47M-0.22M9.39M2.76M22.85M-12.18M-10.65M7.69M8.24M37.69M12.89M10.59M13.72M5.63M13.58M39.13M
Interest ExpensesInt Expense
0.17M0.37M13.05M15.44M17.81M22.52M24.12M24.18M23.77M23.84M24.68M22.03M20.55M19.81M16.49M15.75M
Tax Rate
18.05%14.62%30.53%55.65%38.01%27.56%26.72%56.55%234.89%53.25%-7.35%-9.59%-83.97%389.98%-41.90%3.50%26.18%16.68%873.31%30.55%